A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3
Clinical trial NCT04524208 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04524208
- Sponsor
- Karsten Gavenis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2024-09-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.